Immunis Partners with Japanese Drug Company Toray to Reverse Sarcopenia
Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA) to undertake a project to promote deployment and utilization of Japanese technology of the personal protective (personal protective equipment: PPE in general) to support strengthening infection risk control particularly for preparedness of the deadly infectious diseases such as Ebola Diseases (EVD) that had been spread during 2014-2016 in the Republic of Guinea.
Advanced Catheter Therapies ($ACT), the maker of a localized drug delivery system for the peripheral vasculature, is teaming with Toray Industries ($TORAY) to manufacture, market and sell ACT’s FDA-cleared Occlusion Perfusion Catheter (OPC).nnThe drug delivery device is a targeted therapeutic agent system designed exclusively for the field of peripheral vascular stenosis and restenosis. The company began manufacturing the OPC last year for use in supporting clinical trials and for a targeted test market release.
Japan permits Toray’s Additional Indication of Pruritus Treatment Drug